Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 60760-780

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 60760-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)
Chemical structure of Cyclobenzaprine hydrochloride showing its molecular configuration including the cycloheptene and benzene rings, alongside the dimethylaminopropyl side chain and the hydrochloride component.*
FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 02)

FDA Label Image

78092 (Cyclobenzaprine 780 92)

78092 (Cyclobenzaprine 780 92)
Cyclobenzaprine hydrochloride 7.5 mg film-coated tablets label showing a quantity of 120 tablets. The label includes the NDC 60760-780-92 and mentions the product is packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. The label also includes usage instructions "USE AS DIRECTED" and storage temperature guidelines. Manufacturer details mention Unichem Laboratories Ltd., Goa, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.